The novel ATM-related protein TRRAP is an essential cofactor for the c- Myc and E2F oncoproteins

Cell

Volumn 94, Issue 3, 1998, Pages 363-374

  McMahon, Steven B ^a   Van Buskirk, Heather A ^a   Dugan, Kerri A ^a   Copeland, Terry D ^b   Cole, Michael D ^a  

^a PRINCETON UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; NUCLEAR PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; SEQUENCE HOMOLOGY; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ANIMALIA; EUKARYOTA;

EID: 0032493894     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81479-8     Document Type: Article

References (52)

1. Alitalo, K., Schwab, M., Lin, C.C., Varmus, H.E., and Bishop, J.M. (1983). Homogenously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc. Natl. Acad. Sci. USA 80, 1707-1711.
2. Amati, B., Brooks, M.W., Levy, N., Littlewood, T.D., Evan, G.I., and Land, H. (1993). Oncogenic activity of the c-Myc protein requires dimerization with max. Cell 72, 233-245.
3. Askew, D.S., Ashmun, R.A., Simmons, B.C., and Cleveland, J.L. (1991). Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6, 1915-1922.
4. Ayer, D.E., Lawrence, Q.A., and Eisenman, R.N. (1995). Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologsof yeast represser Sin3. Cell 80, 767-776.
5. Baskaran, R., Wood, L.D., Whitaker, L.L., Canman, C.E., Morgan, S.E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M.B., and Wang, J.Y.J. (1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519.
6. Bello-Fernandez, C., Packham, G., and Cleveland, J.L. (1993). The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90, 7804-7808.
7. Berry, R., Stevens, T.J., Walter, N.A., Wilcox, A.S., Rubano, T., Hopkins, J.A., Weber, J., Goold, R., Soares, M.B., and Sikela, J.M. (1995). Gene-based sequence-tagged-sites (STSs) as the basis for a human gene map. Nat. Genet. 10, 415-423.
8. Brockmann, D., and Esche, H. (1995). Regulation of viral and cellular gene expression by E1A proteins encoded by the oncogenic adenovirus type 12. Curr. Top. Microbiol. Immunol. 199, 81-112.
9. Brough, D.E., Hofmann, T.J., Ellwood, K.B., Townley, R.A., and Cole, M.D. (1995). An essential domain of the c-Myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol. Cell. Biol. 15, 1536-1544.
10. Cole, M.D. (1986). The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet. 20, 361-385.
11. Danska, J.S., Holland, D.P., Mariathasan, S., Williams, K.M., and Guidos, C.J. (1996). Biochemical and genetic defects in the DNA-dependent protein kinase in murine seid lymphocytes. Mol. Cell. Biol. 16, 5507-5517.
12. Desbarats, L., Gaubatz, S., and Eilers, M. (1996). Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev. 10, 447-460.
13. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489.
14. Dynlacht, B.D., Brook, A., Dembski, M., Yenush, L., and Dyson, N. (1994). DNA-binding and trans-activation properties of Drosophila E2Fand DP proteins. Proc. Natl. Acad. Sci. USA 91, 6359-6363.
15. Enoch, T., and Norbury, C. (1995). Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20, 426-430.
16. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-myc protein. Cell 69, 119-128.
17. Freytag, S.O., and Geddes, T.J. (1992). Reciprocal regulation of adipogenesis by myc and C/EBPa. Science 256, 379-382.
18. Freytag, S.O., Dang, C.V., and Lee, W.M.F. (1990). Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ. 1, 339-343.
19. Gallant, P., Shiio, Y., Cheng, P.F., Parkhurst, S.M., and Eisenman, R.N. (1996). Myc and Max homologs in Drosophila. Science 274, 1523-1527.
20. Harlow, E., Whyte, P., Franza, B.R., Jr., and Schley, C. (1986). Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol. 6, 1579-1589.
21. Hartley, K.O., Gell, D., Smith, G.C.M., Zhang, H., Divecha, N., Connelly, M.A., Admon, A., Lees-Miller, S.P., Anderson, C.W., and Jackson, S.P. (1995). DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82, 849-856.
22. Hateboer, G., Timmers, H.T., Rustgi, A.K., Billaud, M., van't Veer, L.J., and Bernards, R. (1993). TATA-binding protein and the retino-blastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein. Proc. Natl. Acad. Sci. USA 90, 8489-8493.
23. Heery, D.M., Kalkhoven, E., Hoare, S., and Parker, M.G. (1997). A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387, 733-736.
24. Helin, K., Harlow, E., and Fattaey, A. (1993). Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13, 6501-6508.
25. Henriksson, M., and Lüscher, B. (1996). Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109-182.
26. Hopp, T.P., Prickett, K.S., Price, V.L., Libby, R.T., March, C.J., Cerretti, D.P., Urdal, D.L., and Conlon, P.J. (1988). A short polypeptide marker sequence useful for recombinant protein identification and purification. Biotechnology 6, 1204-1210.
27. Huang, X., and Miller, W. (1991). A time-efficient, linear-space local similarity algorithm. Adv. Appl. Math. 12, 337-357.
28. Hunter, T. (1995). When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83, 1-4.
29. Kato, G.J., Barrett, J., Villa-Garcia, M., and Dang, C.V. (1990). An amino-terminal c-Myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10, 5914-5920.
30. Lavin, M.F., and Shiloh, Y. (1996). Ataxia-telangiectasia: amultifaceted genetic disorder associated with defective signal transduction. Curr. Opin. Immunol. 8, 459-464.
31. Li, L.H., Nerlov, C., Prendergast, G., MacGregor, D., and Ziff, E.B. (1994). c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13, 4070-4079.
32. MacGregor, D., Li, L.H., and Ziff, E.B. (1996). Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1A with Ras. J. Cell Physiol. 167, 95-105.
33. Mateyak, M.M., Obaya, A.J., Adachi, S., and Sedivy, J.M. (1997). Phenotypes of c-Myc-deficient fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8, 1039-1048.
34. Morgan, S.E., Lovly, C., Pandita, T.K., Shiloh, Y., and Kastan, M.B. (1997). Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17, 2020-2029.
35. Myers, E.W., and Miller, W. (1988). Optimal alignments in linear space. Comput. Appl. Biosci. 4, 11-17.
36. Nevins, J.R., Leone, G., DeGregori, J., and Jakoi, L. (1997). Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173, 233-236.
37. Ohtani, K., and Nevins, J.R. (1994). Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 14, 1603-1612.
38. Penn, L.J.Z., Brooks, M.W., Laufer, E.M., and Land, H. (1990a). Negative autoregulation of c-myc transcription. EMBO J. 9, 1113-1122.
39. Penn, L.J.Z., Brooks, M.W., Laufer, E.M., Littlewood, T.D., Morgenstern, J.P., Evan, G.I., Lee, W.M.F., and Land, H. (1990b). Domains of human c-Myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol. Cell. Biol. 10, 4961-4966.
40. Resar, L.M.S., Dolde, C., Barrett, J.F., and Dang, C.V. (1993). B-myc inhibits neoplastic transformation and transcriptional activation by c-myc. Mol. Cell. Biol. 13, 1130-1136.
41. Sakamuro, D., Elliott, K.J., Wechsler-Reya, R., and Prendergast, G.G. (1996). BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat. Genet. 14, 69-77.
42. Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A.I., and DePinho, R.A. (1995). An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional represser SIN3. Cell 80, 777-786.
43. Schreiber-Agus, N., Stein, D., Chen, K., Glotz, J.S., Stevens, L., and DePinho, R.A. (1997). Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype. Proc. Natl. Acad. Sci. USA 94, 1235-1240.
44. Shan, B., Durfee, T., and Lee, W.H. (1996). Disruption of RB-E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA 93, 679-684.
45. Sikorski, R.S., Boguski, M.S., Goebl, M., and Mieter, P. (1990). A repeating amino acid motif in CDC23 defines a family of proteins and a new relationship among genes required for mitosis and RNA synthesis. Cell 60, 307-317.
46. Sommer, A., Bousset, K., Kremmer, E., Austen, M., and Lüscher, B. (1998). Identification and characterization of specific DNA-binding complexes containing members of the Myc/Max/Mad network of transcriptional regulators. J. Biol. Chem. 273, 6632-6642.
47. Stone, J., DeLange, T., Ramsay, G., Jakobovits, E., Bishop, J.M., Varmus, H., and Lee, W. (1987). Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7, 1697-1709.
48. Taylor, S.S., Radzio-Andzelm, E., and Hunter, T. (1995). How do protein kinases discriminate between serine/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 9, 1255-1266.
49. Toker, A., and Cantley, L.C. (1997). Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387, 673-676.
50. Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K., and Rosenfeld, M.G. (1997). The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 387, 677-684.
51. Zakian, V.A. (1995). ATM-related genes: what do they tell us about functions of the human gene? Cell 82, 685-687.
52. Zheng, X.-F., Fiorentino, D., Chen, J., Crabtree, G.R., and Schreiber, S.L. (1995). TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82, 121-130.